Tonix Pharmaceuticals Holding C

Historical 13F Holders

Symbol
TNXP
CUSIP
890260854
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 890260854 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Sabby Management, LLC 13G/A
0.7% 1/3/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 100 $1.20 k
2024 Q2 2 28.2 k $19.6 k
2024 Q1 44 12.0 M $2.24 M
2023 Q4 43 14.4 M $5.81 M
2023 Q3 33 3.69 M $2.01 M
2023 Q2 33 1.02 M $1.62 M